Autor: "Li N" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: NIPBL-mediated RAD21 facilitates tumorigenicity by the PI3K pathway in non-small-cell lung cancer.
Autorzy:: Xu X; Department of Radiation Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 507 Zhengmin Road, Shanghai, China.
Wang D; Key laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Zhejiang Cancer Research Institute, 38 Guangji Road, Hangzhou, China.
Xu W; Key laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Zhejiang Cancer Research Institute, 38 Guangji Road, Hangzhou, China.
Li H; Key laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Zhejiang Cancer Research Institute, 38 Guangji Road, Hangzhou, China.; The Second Clinical Medical College of Wenzhou Medical University, 268 West Xueyue Road, Wenzhou, China.
Chen N; The Second Clinical Medical College of Zhejiang Chinese Medical University, 548 Binwen Road, Hangzhou, China.
Li N; The Second Clinical Medical College of Wenzhou Medical University, 268 West Xueyue Road, Wenzhou, China.
Yao Q; The Second Clinical Medical College of Wenzhou Medical University, 268 West Xueyue Road, Wenzhou, China.
Chen W; Key laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Zhejiang Cancer Research Institute, 38 Guangji Road, Hangzhou, China. .
Zhong J; School of Life Science and Technology, Southeast University, 2 Sipailou, Nanjing, China. .
Mao W; Key laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Zhejiang Cancer Research Institute, 38 Guangji Road, Hangzhou, China. .; The Second Clinical Medical College of Wenzhou Medical University, 268 West Xueyue Road, Wenzhou, China. .; Department of Thoracic Oncology, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, 1 Banshan East Road, Hangzhou, China. .; Pokaż więcej
Źródło:: Communications biology [Commun Biol] 2024 Feb 20; Vol. 7 (1), pp. 206. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/metabolism
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Humans ; Phosphatidylinositol 3-Kinases ; Phosphatidylinositol 3-Kinase ; Lysine ; Cell Cycle Proteins/genetics ; Cell Cycle Proteins/metabolism ; DNA-Binding Proteins/metabolism ; Jumonji Domain-Containing Histone Demethylases/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Opportunistic lung cancer screening with low-dose computed tomography in National Cancer Center of China: The first 14 years' experience.
Autorzy:: Tang W; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu L; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Huang Y; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhao S; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang J; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liang M; Radiology Department, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Jin Y; Department Nuclear Medicine (PET-CT Center), National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhou L; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu Y; Department Nuclear Medicine (PET-CT Center), National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Tang Y; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xu Z; Department of Cancer Prevention, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhang K; Department of Cancer Prevention, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Tan F; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Bi N; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang Z; CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang F; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li N; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wu N; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Department Nuclear Medicine (PET-CT Center), National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6914. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:: Journal Article
MeSH Terms:: Early Detection of Cancer*
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/epidemiology
Adult ; Female ; Humans ; Male ; Middle Aged ; China/epidemiology ; Tomography ; East Asian People

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: The current status and future of ADC therapy for small cell Lung Cancer: a promising approach.
Autorzy:: Zhou J; Clinical Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Ma P; Clinical Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Tang Q; Clinical Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang S; Clinical Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. .; Cancer Hospital, State Key Laboratory of Molecular Oncology, Department of Clinical Trial Center, National Cancer Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Chaoyang, Beijing, China. .
Li N; Clinical Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. .; Cancer Hospital, State Key Laboratory of Molecular Oncology, Department of Clinical Trial Center, National Cancer Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Chaoyang, Beijing, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2023 Nov 13; Vol. 21 (1), pp. 808. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:: Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Small Cell Lung Carcinoma*/therapy
Lung Neoplasms*/therapy
Carcinoma, Non-Small-Cell Lung*
Humans ; Diffusion Magnetic Resonance Imaging

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Predictive value of F-FDG PET/CT and serum tumor markers for tumor mutational burden in patients with non-small cell lung cancer.
Autorzy:: Zhang Q; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Tao X; Department of Nuclear Medicine (PET-CT Center), National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yuan P; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhang Z; Department of Nuclear Medicine (PET-CT Center), National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Ying J; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Guo L; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li N; Department of Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang S; Department of Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li J; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Department of Nuclear Medicine (PET-CT Center), National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu Y; Department of Nuclear Medicine (PET-CT Center), National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Guo W; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhao S; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wu N; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Department of Nuclear Medicine (PET-CT Center), National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Nov; Vol. 12 (22), pp. 20864-20877. Date of Electronic Publication: 2023 Nov 15.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/metabolism
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Adenocarcinoma*
Carcinoma, Squamous Cell*
Male ; Female ; Humans ; Positron Emission Tomography Computed Tomography ; Fluorodeoxyglucose F18 ; Biomarkers, Tumor/genetics ; Retrospective Studies ; ErbB Receptors ; Tumor Burden ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Development and validation of a risk model with variables related to non-small cell lung cancer in patients with pulmonary nodules: a retrospective study.
Autorzy:: Liao Z; The Affiliated Lihuili Hospital, Ningbo University, Ningbo, 315041, Zhejiang, China.
Zheng R; Ningbo Yinzhou NO.2 Hospital, Ningbo, 315192, Zhejiang, China.
Li N; Department of Cardiothoracic Surgery, Li Huili Hospital Affiliated to Ningbo University, Xingning Road 57, Ningbo, 315041, Zhejiang, China.
Shao G; Department of Cardiothoracic Surgery, Li Huili Hospital Affiliated to Ningbo University, Xingning Road 57, Ningbo, 315041, Zhejiang, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Sep 18; Vol. 23 (1), pp. 872. Date of Electronic Publication: 2023 Sep 18.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/epidemiology
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/epidemiology
Multiple Pulmonary Nodules*/diagnostic imaging
Hypertension*
Humans ; Retrospective Studies ; Fibrinogen

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Systematic analysis of histone acetylation regulators across human cancers.
Autorzy:: Song C; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China.
Liu X; Department of Hematology, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China.
Lin W; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China.
Lai K; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China.
Pan S; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China.
Lu Z; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China.
Li D; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China.
Li N; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China. .
Geng Q; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Aug 08; Vol. 23 (1), pp. 733. Date of Electronic Publication: 2023 Aug 08.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Renal Cell*/genetics
Kidney Neoplasms*/genetics
Kidney Neoplasms*/pathology
Lung Neoplasms*/genetics
Humans ; Histones/metabolism ; Acetylation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: A strategy to reduce the false-positive rate after low-dose computed tomography in lung cancer screening: A multicenter prospective cohort study.
Autorzy:: Wu Z; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Tan F; Department of Thoracic surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xie Y; The Second People's Hospital of Liaocheng, Shandong, China.
Tang W; Department of Thoracic surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang F; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xu Y; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Cao W; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Qin C; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Dong X; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zheng Y; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Luo Z; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang C; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhao L; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xia C; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li J; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li R; Department of Thoracic surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Feng F; Department of Thoracic surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li J; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Ren J; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Shi J; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Cui H; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Shen S; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Wu N; PET-CT Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chen W; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li N; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
He J; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Department of Thoracic surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Jul; Vol. 12 (13), pp. 14781-14793. Date of Electronic Publication: 2023 May 18.
Typ publikacji:: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/epidemiology
Multiple Pulmonary Nodules*
Humans ; Early Detection of Cancer/methods ; Prospective Studies ; Mass Screening/methods ; Tomography/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: The kinesin light chain-2, a target of mRNA stabilizing protein HuR, inhibits p53 protein phosphorylation to promote radioresistance in NSCLC.
Autorzy:: Qiao S; Department of Radiation Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Jiang Y; Department of Radiation Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Li N; Department of Radiation Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Zhu X; Department of Radiation Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2023 Jun; Vol. 14 (16), pp. 1440-1450. Date of Electronic Publication: 2023 Apr 13.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/metabolism
Lung Neoplasms*/genetics
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/metabolism
Humans ; Cell Line, Tumor ; Kinesins/genetics ; Kinesins/metabolism ; Phosphorylation ; RNA, Messenger/metabolism ; Tumor Suppressor Protein p53/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Real-world treatment and prognostic factors for survival in ALK+ non-small cell lung cancer (NSCLC) patients with brain metastases in China.
Autorzy:: Li N; The First Clinical Medical College of Wenzhou Medical University, Wenzhou, China.; Department of Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Xie M; Department of Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.; The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
Zhou Z; Department of Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.; The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
Sheng J; Department of Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Yu X; Department of Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Fan Y; Department of Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2023 Jan; Vol. 14 (3), pp. 237-245. Date of Electronic Publication: 2022 Nov 21.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Brain Neoplasms*/secondary
Humans ; Anaplastic Lymphoma Kinase ; Prognosis ; Protein Kinase Inhibitors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Prognostic Biomarkers after Radiotherapy for Nonsmall Cell Lung Cancer Based on Bioinformatics Analysis.
Autorzy:: Li K; Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China.
Wang S; Department of Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Clinical Research Center for Cancer, Tianjin 300060, China.
Li N; Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China.
Zhao W; Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China.
He N; Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China.
Wang J; Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China.
Ji K; Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China.
Zhang M; Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China.
Song H; Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China.
Liu Q; Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China.
Du L; Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China.; Pokaż więcej
Źródło:: BioMed research international [Biomed Res Int] 2022 Dec 15; Vol. 2022, pp. 6405228. Date of Electronic Publication: 2022 Dec 15 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/genetics
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/metabolism
Humans ; Prognosis ; Biomarkers ; Computational Biology ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Gene Expression Regulation, Neoplastic ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Survival outcomes following treatment delays among patients with early-stage female cancers: a nationwide study.
Autorzy:: Min Y; Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Liu Z; Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Huang R; School of Nursing, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Li R; Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Jin J; Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Wei Z; Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
He L; Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Pei Y; Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Li N; Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Su Y; Department of Rehabilitation, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. .
Hu X; West China School of Nursing, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. .
Peng X; Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2022 Dec 03; Vol. 20 (1), pp. 560. Date of Electronic Publication: 2022 Dec 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Uterine Cervical Neoplasms*
Carcinoma, Non-Small-Cell Lung*
COVID-19*
Lung Neoplasms*
Adenocarcinoma*
Thyroid Neoplasms*
Breast Neoplasms*
Colorectal Neoplasms*
Humans ; Female ; Male ; Time-to-Treatment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Chinese never smokers with adenocarcinoma of the lung are younger and have fewer lymph node metastases than smokers.
Autorzy:: Shan L; Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, 361003, Xiamen, People's Republic of China.
Zhang L; Priority Area Chronic Lung Diseases, Research Center Borstel, Member of the German Center for Lung Research (DZL), 23845, Borstel, Germany.; Borstel, Germany.
Zhu X; Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, 361003, Xiamen, People's Republic of China.
Wang Z; Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, 361003, Xiamen, People's Republic of China.
Fang S; Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, 361003, Xiamen, People's Republic of China.
Lin J; Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, 361003, Xiamen, People's Republic of China.
Wang J; Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, 361003, Xiamen, People's Republic of China.
Li N; Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, 361003, Xiamen, People's Republic of China.
Liu H; Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, 361003, Xiamen, People's Republic of China.
Zhang X; Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, 361003, Xiamen, People's Republic of China.
Feng Y; Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, 361003, Xiamen, People's Republic of China.
Liu J; Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, 361003, Xiamen, People's Republic of China.
Pan J; Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, 361003, Xiamen, People's Republic of China.
Ye G; Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, 361003, Xiamen, People's Republic of China.
Yu X; Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, 361003, Xiamen, People's Republic of China.
Tufman A; Department of Medicine V, Member of the German Center for Lung Research, University Hospital, LMU Munich, Munich, Germany.; Institute for Social Medicine and Epidemiology, University of Luebeck, Luebeck, Germany.
Katalinic A; Teaching Hospital of Fujian Medical University, 361003, Xiamen, China.
Goldmann T; Pathology, Research Center Borstel, Member of the German Center for Lung Research (DZL), Borstel, Germany.; Borstel, Germany.
Petersen F; Priority Area Chronic Lung Diseases, Research Center Borstel, Member of the German Center for Lung Research (DZL), 23845, Borstel, Germany.; Borstel, Germany.
Jiang J; Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, 361003, Xiamen, People's Republic of China.
Geng G; Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, 361003, Xiamen, People's Republic of China. .; Teaching Hospital of Fujian Medical University, 361003, Xiamen, China. .
Yu X; Priority Area Chronic Lung Diseases, Research Center Borstel, Member of the German Center for Lung Research (DZL), 23845, Borstel, Germany. .; Borstel, Germany. .; Pokaż więcej
Źródło:: Respiratory research [Respir Res] 2022 Oct 29; Vol. 23 (1), pp. 293. Date of Electronic Publication: 2022 Oct 29.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/epidemiology
Lung Neoplasms*/pathology
Adenocarcinoma*/epidemiology
Adenocarcinoma*/pathology
Carcinoma, Squamous Cell*/diagnosis
Carcinoma, Squamous Cell*/epidemiology
Humans ; Lymphatic Metastasis ; Smokers ; Neoplasm Staging ; Lung/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are correlated with tumor-node-metastasis stages in patients with non-small cell lung cancer.
Autorzy:: Cheng H; Department of Cardiothoracic Surgery, Chengdu Second People's Hospital, Chengdu, China.
Bhushan S; Department of Cardiothoracic Surgery, Chengdu Second People's Hospital, Chengdu, China.
Li N; Department of Oncology, West China Fourth Hospital, Sichuan University, Chengdu, China.
Xiao Z; Department of Cardiothoracic Surgery, Chengdu Second People's Hospital, Chengdu, China.
Gao K; Department of Cardiothoracic Surgery, Chengdu Second People's Hospital, Chengdu, China.; Pokaż więcej
Źródło:: Journal of cancer research and therapeutics [J Cancer Res Ther] 2022 Oct-Dec; Vol. 18 (6), pp. 1666-1673.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/surgery
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/surgery
Lung Neoplasms*/pathology
Neoplasms, Second Primary*/pathology
Humans ; Neutrophils/pathology ; Retrospective Studies ; Platelet Count ; Prognosis ; Lymphocytes/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Comprehensive analysis reveals the potential value of inflammatory response genes in the prognosis, immunity, and drug sensitivity of lung adenocarcinoma.
Autorzy:: Song C; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China.
Pan S; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China.
Li D; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China.
Hao B; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China.
Lu Z; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China.
Lai K; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China.
Li N; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China.
Geng Q; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China. .; Pokaż więcej
Źródło:: BMC medical genomics [BMC Med Genomics] 2022 Sep 18; Vol. 15 (1), pp. 198. Date of Electronic Publication: 2022 Sep 18.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Gene Expression Regulation, Neoplastic ; Humans ; Neoplasm Staging ; Prognosis ; Tumor Microenvironment/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: ROS1-positive non-small cell lung cancer (NSCLC): biology, diagnostics, therapeutics and resistance.
Autorzy:: Yu ZQ; Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, PR China.
Wang M; Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, PR China.
Zhou W; Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, PR China.
Mao MX; Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, PR China.
Chen YY; Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, PR China.
Li N; Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, PR China.
Peng XC; Laboratory of Oncology, Center for Molecular Medicine, Jingzhou, PR China.; Department of Pathophysiology, School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, PR China.
Cai J; Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, PR China.
Cai ZQ; Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, PR China.; Pokaż więcej
Źródło:: Journal of drug targeting [J Drug Target] 2022 Sep; Vol. 30 (8), pp. 845-857. Date of Electronic Publication: 2022 Jun 14.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/pathology
Biology ; Crizotinib/therapeutic use ; Humans ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Protein-Tyrosine Kinases/metabolism ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Preoperative Serum Triglyceride to High-Density Lipoprotein Cholesterol Ratio Can Predict Prognosis in Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study.
Autorzy:: Li J; Department of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Ma C; Department of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Yuan X; Department of Surgery, First Affiliated Hospital of Nanchang University, Nanchang 330006, China.; Department of Surgery, Third Affiliated Hospital of Nanchang University, Nanchang 330008, China.
Wang X; Department of Surgery, First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Li N; Department of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Yu R; Department of Surgery, First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Liao H; Department of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Aug 25; Vol. 29 (9), pp. 6125-6136. Date of Electronic Publication: 2022 Aug 25.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/surgery
Lung Neoplasms*
Biomarkers ; Cholesterol, HDL ; Humans ; Lipoproteins ; Prognosis ; Retrospective Studies ; Triglycerides

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: The diagnostic value of has_circ_0006423 in non-small cell lung cancer and its role as a tumor suppressor gene that sponges miR-492.
Autorzy:: Zhu L; Department of Cardiothoracic Surgery, Ningbo Medical Center Lihuili Hospital, 57 Xingning Road, Yinzhou District, Ningbo City, 315040, Zhejiang, China.; Department of Cardiothoracic Surgery, Lihuili Hospital Affiliated to Ningbo University, Ningbo City, Zhejiang, China.
Sun L; Department of Cardiothoracic Surgery, Ningbo Medical Center Lihuili Hospital, 57 Xingning Road, Yinzhou District, Ningbo City, 315040, Zhejiang, China.; Department of Cardiothoracic Surgery, Lihuili Hospital Affiliated to Ningbo University, Ningbo City, Zhejiang, China.
Xu G; Department of Cardiothoracic Surgery, Ningbo Medical Center Lihuili Hospital, 57 Xingning Road, Yinzhou District, Ningbo City, 315040, Zhejiang, China.; Department of Cardiothoracic Surgery, Lihuili Hospital Affiliated to Ningbo University, Ningbo City, Zhejiang, China.
Song J; Department of Cardiothoracic Surgery, Ningbo Medical Center Lihuili Hospital, 57 Xingning Road, Yinzhou District, Ningbo City, 315040, Zhejiang, China.; Department of Cardiothoracic Surgery, Lihuili Hospital Affiliated to Ningbo University, Ningbo City, Zhejiang, China.
Hu B; Department of Cardiothoracic Surgery, Ningbo Medical Center Lihuili Hospital, 57 Xingning Road, Yinzhou District, Ningbo City, 315040, Zhejiang, China.; Department of Cardiothoracic Surgery, Lihuili Hospital Affiliated to Ningbo University, Ningbo City, Zhejiang, China.
Fang Z; Department of Cardiothoracic Surgery, Ningbo Medical Center Lihuili Hospital, 57 Xingning Road, Yinzhou District, Ningbo City, 315040, Zhejiang, China.; Department of Cardiothoracic Surgery, Lihuili Hospital Affiliated to Ningbo University, Ningbo City, Zhejiang, China.
Dan Y; Department of Cardiothoracic Surgery, Ningbo Medical Center Lihuili Hospital, 57 Xingning Road, Yinzhou District, Ningbo City, 315040, Zhejiang, China.; Department of Cardiothoracic Surgery, Lihuili Hospital Affiliated to Ningbo University, Ningbo City, Zhejiang, China.
Li N; Department of Cardiothoracic Surgery, Ningbo Medical Center Lihuili Hospital, 57 Xingning Road, Yinzhou District, Ningbo City, 315040, Zhejiang, China. rebecca_.; Department of Cardiothoracic Surgery, Lihuili Hospital Affiliated to Ningbo University, Ningbo City, Zhejiang, China. rebecca_.; Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China. rebecca_.
Shao G; Department of Cardiothoracic Surgery, Ningbo Medical Center Lihuili Hospital, 57 Xingning Road, Yinzhou District, Ningbo City, 315040, Zhejiang, China. .; Department of Cardiothoracic Surgery, Lihuili Hospital Affiliated to Ningbo University, Ningbo City, Zhejiang, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2022 Aug 12; Vol. 12 (1), pp. 13722. Date of Electronic Publication: 2022 Aug 12.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Cell Line, Tumor ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Genes, Tumor Suppressor ; Humans ; RNA, Circular/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Real-world utilization of PD-1/PD-L1 inhibitors with palliative radiotherapy in patients with metastatic non-small cell lung cancer.
Autorzy:: Zhou ZC; The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.; Department of Thoracic Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, China.
Chen KY; Department of Thoracic Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, China.; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Li N; Department of Thoracic Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, China.; The First Clinical Medical College of Wenzhou Medical University, Wenzhou, China.
Xie MY; The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.; Department of Thoracic Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, China.
Sheng JM; Department of Thoracic Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, China.; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Fan Y; Department of Thoracic Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, China.; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Huang ZY; Department of Thoracic Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, China.; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2022 Aug; Vol. 13 (16), pp. 2291-2300. Date of Electronic Publication: 2022 Jun 28.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Lung Neoplasms*/drug therapy
Lung Neoplasms*/metabolism
Lung Neoplasms*/radiotherapy
B7-H1 Antigen/metabolism ; Humans ; Immune Checkpoint Inhibitors ; Programmed Cell Death 1 Receptor/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Galectin expression detected by Ga-galectracer PET as a predictive biomarker of radiotherapy resistance.
Autorzy:: Lu D; Medical Isotopes Research Center and Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
Zhou H; Medical Isotopes Research Center and Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
Li N; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China.
Wang Y; Medical Isotopes Research Center and Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
Zhang T; Medical Isotopes Research Center and Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
Wang F; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China.
Liu N; Medical Isotopes Research Center and Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
Zhu H; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China.; NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Peking University Cancer Hospital and Institute, Beijing, 100142, China.
Zhang J; Department of Nuclear Medicine, Chinese PLA General Hospital, Beijing, 100853, China.
Yang Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China.; NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Peking University Cancer Hospital and Institute, Beijing, 100142, China.
Liu Z; Medical Isotopes Research Center and Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China. .; NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Peking University Cancer Hospital and Institute, Beijing, 100142, China. .; Pokaż więcej
Źródło:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Jul; Vol. 49 (8), pp. 2746-2760. Date of Electronic Publication: 2022 Feb 02.
Typ publikacji:: Journal Article
MeSH Terms:: Gallium Radioisotopes*
Lung Neoplasms*/pathology
Animals ; Biomarkers ; Humans ; Hypoxia ; Mice ; Positron Emission Tomography Computed Tomography/methods ; Positron-Emission Tomography/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Higher accuracy of [ F]FDG PET/CT in clinical staging of NSCLC.
Autorzy:: Zhou X; Key Laboratory of Carcinogenesis and Translational Research, (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Rd, Beijing, 100142, China.
Wang S; Key Laboratory of Carcinogenesis and Translational Research, (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Rd, Beijing, 100142, China.
Xu X; Key Laboratory of Carcinogenesis and Translational Research, (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Rd, Beijing, 100142, China.
Meng X; Key Laboratory of Carcinogenesis and Translational Research, (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Rd, Beijing, 100142, China.
Zhang H; Key Laboratory of Carcinogenesis and Translational Research, (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Rd, Beijing, 100142, China.
Zhang A; Key Laboratory of Carcinogenesis and Translational Research, (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Rd, Beijing, 100142, China.
Song Y; Key Laboratory of Carcinogenesis and Translational Research, (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Rd, Beijing, 100142, China.
Zhu H; Key Laboratory of Carcinogenesis and Translational Research, (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Rd, Beijing, 100142, China.
Yang Z; Key Laboratory of Carcinogenesis and Translational Research, (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Rd, Beijing, 100142, China. .
Li N; Key Laboratory of Carcinogenesis and Translational Research, (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Rd, Beijing, 100142, China. .; Pokaż więcej
Źródło:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Jul; Vol. 49 (8), pp. 2983-2993. Date of Electronic Publication: 2022 May 11.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Fluorodeoxyglucose F18 ; Heterocyclic Compounds, 1-Ring ; Humans ; Positron Emission Tomography Computed Tomography/methods ; Prospective Studies ; Quinolines ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Li N"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język